Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Opendate Raises $14M Series A Led by High Alpha to Accelerate a New Operating System for Live Events
-
Pete Pharma and Curexa Enter Strategic Partnership to Accelerate Innovation in Compounded Therapies for the Telehealth Market
-
AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results
-
After Las Vegas CES ElephantSqlDB® Opens $46M Pre-IPO Round Following $143M Enterprise Pipeline
-
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
-
Incyte to Report Fourth Quarter and Year-End 2025 Financial Results
-
Arch Painting® Predicts Trends in Commercial Painting for 2026
-
SimBioSys Appoints Senthil Periaswamy as Chief AI & Technology Officer
-
Creditsafe Research Finds Sales & Finance Are Aligned in Regret Over Risky Deals
-
BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th
-
Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)
-
AUO Achieves a Landmark Patent Litigation Victory in the U.S. District Court for the Eastern District of Texas
-
Central Bancompany, Inc. Reports Fourth Quarter and Full-Year 2025 Results
-
Fauna Robotics Unveils Sprout: A Lightweight, Interactive, and Capable Developer-Ready Humanoid Platform
-
Axis Insurance Partners with Edgewater Financial Group, Kearns Edgewater Financial Services, and Kearns Insurance Corporation
-
ASSP Announces Strategic Framework to Drive Workplace4 Safety Beyond Compliance
-
EagleNXT Highlights RedEdge-P™ Green Sensor Sales Growth Following August 2025 Launch
-
Gwyneth Paltrow to Keynote Meltwater Summit 2026
-
Gabelli Hosts 36th Annual Pump, Valve, and Water Systems Symposium
-
OSS Announces New Multi-Year Platform Award with Top-Tier Aerospace Prime Contractor
-
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverage Distribution Across Canada Through Walmart Canada and McKesson Canada
-
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
-
Weatherford Announces Quarterly Dividend, Increases Payout by 10%
-
AssetMark Launches Growth Consulting, an 18-month Consulting Service to help Advisors Achieve Sustained, Measurable Growth
-
Vanguard Grows Battery Technology Partner Program with OPS Controls
-
Power Suppliers See Flexible Load Strategies as Critical to Operations as Data Center Growth Increases, According to OBM Report
-
First Advantage to Sponsor Accomplished LPGA Professional Lauren Coughlin
-
LPL Welcomes Moto Wealth Partners to Linsco
-
Circle Cardiovascular Delivers a Unified Cardiac Imaging Platform
-
Rocket Doctor Signs New Contract with Major U.S. Insurer, Expanding Access to an Additional 175,000 Members Across California
-
EVgo Races Ahead on NACS With Nearly 100 Stalls Live Today, Hundreds More Coming in 2026
-
Richtech Robotics Collaborates with Microsoft to Advance Agentic AI in Real-World Robotics Applications
-
Most Consumers Are Aware of AI, but One-Third Don’t Want It in Their Devices, Circana Reports
-
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026
-
Northridge Finance, a division of the Bank of Ireland, goes live with NETSOL’s Transcend Finance platform to support its growth strategy
-
Provident Bank Announces an Additional $50,000 in Grants to 5 Non-Profit Organizations
-
Science 37 Appoints Kelly Johnston McKee as VP of Strategy & Transformation
-
Veriff Sets New Industry Benchmark: 100% Detection Rate of Synthetic Identity Documents in Global IDNet Testing
-
JFB Construction Holdings Awarded Contract of Approximately $11 Million for the Construction of Eight Homes in Jupiter, Fla.
-
Discuss Recognized as a Leader in Experience Research Platforms, Q1 2026 Report by Independent Research Firm
-
Fairtrade America: Statement on Cocoa Alternatives
-
Reykjavik Energy | Renewal of market-making contracts
-
Lumber Wins Alliance Partner of the Year and Presidents Club Awards at Acumatica Summit 2026
-
Shareholders’ Nomination Committee’s Proposals to Annual General Meeting 2026 concerning the Number of the Board Members, Their Remuneration and Reimbursement of Their Costs, and Nomination of the
-
Tax Season Begins as IRS Refund Delays Loom, Clear Start Tax Advises Taxpayers on What to Expect
-
Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel (Generic Plavix(R)) to Address Gastric Bleeding Risks
-
Will Forte Teams Up with Teva to Get Real About Huntington’s Disease with ‘Honestly HD’
-
Bebuzee ($BBUZ) Ignites Global Surge as Next-Gen Super App Accelerates Toward Trillion-Dollar Opportunity
-
Temas Strengthens Board to Support Growth Strategy and Critical Minerals Advancement
-
Sierra Ventures Announces Shomik Ghosh as Partner to Continue Strengthening Early-Stage Investing Across Frontier and Applied AI
